Document:

lidhairexh10_11.htm

Exhibit 10.11

 

CONSULTING SERVICES AGREEMENT

 

This Consulting Agreement (the "Agreement") is entered into this 15th day of August, 2009 by and between:

IFG Investments Services, Inc., a Nevis Corporation                                    (the “Consultant”)

Ram's Business Complex

Stoney Grove,  Box 822

Charlestown, Nevis   Federation of St Kitts & Nevis

and

China Children Pharmaceutical Inc., a PCR Corporation                               (the “Company”)

Rooms 2201-03 22/F World Wide House,

19 Des Voeux Road Central, HK

RECITALS

WHEREAS, the Company is in need of assistance in the public company sector including advising on a merger/acquisition transaction, NASDAQ and Hong Kong Stock Exchange Listing applications, SEC filings including but not limited to, Form 8-K, Registration Statement support; and

WHEREAS, Consultant has agreed to perform consulting work for the Company in providing Merger/Acquisition support, NASDAQ and Hong Kong listing support and other consulting services and other related activities as directed by the Company;  NOW, THEREFORE, the parties hereby agree as follows:

1. Consultant's Services. Consultant shall be available and shall provide to the Company professional

consulting services in the areas of Merger/Acquisition support, NASDAQ and Hong Kong listing support and other consulting services support ("Consulting services") as requested.

2. Consideration.

A. RATE.  In consideration for the Consulting Services to be performed by Consultant under this Agreement, the Company will pay Consultant at the rate of 600,000 warrants with registration rights at a $3.00 exercise price   with piggy-back warrants with registration right attached at a $5.00 exercise price   (SIX
HUNDRED THOUSAND WARRANTS WITH REGISTRATION RIGHTS) total warrants issuable at the closing of the acquisition or merger for time spent on Consulting Services.

B.  EXPENSES. Additionally, the Company will pay Consultant for the following expenses incurred while the Agreement between Consultant and the Company exists:

	
  
	
●
	
All travel expenses to and from all work sites

	
  
	
●
	
Meal expenses;

	
  
	
●
	
Administrative expenses;

	
  
	
●
	
Lodging Expenses if work demands overnight stays; and

	
  
	
●
	
Miscellaneous travel-related expenses (parking and tolls).

Consultant shall submit written documentation and receipts where available itemizing the dates on which expenses were incurred. The Company shall pay Consultant the amounts due pursuant to submitted reports within 14 days after a report is received by the Company.

3. Independent Contractor.  Nothing herein shall be construed to create an employer-employee relationship between the Company and Consultant. Consultant is an independent contractor and not an employee of the Company or any of its subsidiaries or affiliates. The consideration set
forth in Section 2 shall be the sole consideration due Consultant for the services rendered hereunder. It is understood that the Company will not

  

Page 1

  

CONSULTING SERVICES AGREEMENT

withhold any amounts for payment of taxes from the compensation of Consultant hereunder. Consultant will not represent to be or hold herself out as an employee of the Company.

4. Confidentiality.  In the course of performing Consulting Services, the parties recognize that Consultant may come in contact with or become familiar with information which the Company or its subsidiaries or affiliates may consider confidential. This information may include, but
is not limited to, information pertaining to the Company [specify] systems, which information may be of value to a competitor. Consultant agrees to keep all such information confidential and not to discuss or divulge it to anyone other than appropriate Company personnel or their designees.

5. Term. This Agreement shall commence on August 15, 2009 and shall terminate on a August 14, 2010, unless earlier terminated by either party hereto. Either party may terminate this Agreement upon Thirty (30) days prior written notice. The Company may, at its option, renew this Agreement
for an additional One (1) year term on the same terms and conditions as set forth herein by giving notice to Consultant of such intent to renew on or before July 14, 2010.

6. Notice.  Any notice or communication permitted or required by this Agreement shall be deemed effective when personally delivered or deposited, postage prepaid, in the first class mail of the United States properly addressed to the appropriate party at the address set forth below:

Notices to Consultant:

 

IFG Investments Services, Inc., a Nevis Corporation

Attention: Daniel MacMullin

Ram's Business Complex

Stoney Grove,

Box 822

Charlestown, Nevis

Federation of St Kitts & Nevis

Notices to the Company:

 

China Children Pharmaceutical, Inc.

Rooms 2201-03 22/F World Wide House,

19 Des Voeux Road Central, HK

7. Miscellaneous.

7.1 Entire Agreement and Amendments.  This Agreement constitutes the entire agreement of the parties with regard to the subject matter hereof, and replaces and supersedes all other agreements or understandings, whether written
or oral. No amendment or extension of the Agreement shall be binding unless in writing and signed by both parties.

7.2 Binding Effect, Assignment.  This Agreement shall be binding upon and shall inure to the benefit of Consultant and the Company and to the Company's successors and assigns. Nothing in this Agreement shall be construed to permit the assignment by Consultant of any of its rights
or obligations hereunder, and such assignment is expressly prohibited without the prior written consent of the Company.

7.3 Governing Law, Severability.  This Agreement shall be governed by the laws of the Nevis. The invalidity or unenforceability of any provision of the Agreement shall not affect the validity or enforceability of any other provision.

  

Page 2

  

CONSULTING SERVICES AGREEMENT

 

WHEREFORE, the parties have executed this Agreement as of the date first written above.

China Children Pharmaceutical, Inc.:

By:

Jun Xia, Chief Executive Officer

Date: August 15, 2009

 

 

 

IFG Investments Services, Inc.

By:

Daniel MacMullin, President

August 15, 2009

 

 

 

 

 

 

 

 

 

 

 

 

 

 

  

Page 3lidhairexh10_12.htm

Exhibit 10.12

DONAHUE & ASSOCIATIONS

INVESTOR RELATIONS

 

 

THIS AGREEMENT (“Agreement”) dated August 15, 2009, is by and between:

 

China National Information Network                                                                                   (“Agency”)

54 Veterans Boulevard

Strafford, CT 06615

 

and

China Children Pharmaceutical, Inc.                                                                                   (“Company”)

Rooms 2201-03 22/F World Wide House,

19 Des Voeux Road Central, HK

 

with respect to investor relations services to be provided by Agency to China Children Pharmaceutical, Inc.

SERVICES.   China Children Pharmaceutical hereby engages Agency to provide investor relations services to China Children Pharmaceutical as of August 15, 2009 until December 15, 2010.  Unless written notification is received 30 days in advance, the Agreement is automatically
renewable for one year.

 

TERM.  August 15, 2009 through December 31, 2010.

 

COMPENSATION.   Agency will receive compensation for its services hereunder in the amount 400,000 Warrants with Registration Rights with a $3.00 exercise price with piggy-back warrants attached with a $5.00 exercise price (FOUR HUNDRED THOUSAND WARRANTS WITH REGISTRATION RIGHTS)
total warrants issuable at the closing of the acquisition or merger.  The warrants will be issuable at the closing of the merger approximately September 30, 2009.

 

EXPENSES.   During the Term, China Children Pharmaceutical will reimburse Agency for Agency’s actual, direct, out-of-pocket costs, for properly documented, verifiable, non-personal, reasonable business expenses incurred by Agency in connection with
and directly relating to Agency’s performance of its services under this Agreement, such as long distance telephone charges, photocopies at a rate not to exceed $.10 per copy, newswire distribution, postage and miscellaneous expenses as necessary.  Expenses in excess of $500 shall be approved in writing by China Children Pharmaceutical in advance.

 

REPRESENTATIONS/WARRANTIES. Agency represents and warrants the following:

 

All of Agency’s services shall be provided in a timely and competent manner in accordance with industry quality standards;

  

1

  

DONAHUE & ASSOCIATIONS

INVESTOR RELATIONS

 

Any materials or documents submitted, developed or created by Agency for China Children Pharmaceutical shall not violate or infringe upon a trademark, trade name, copyright, patent, literary or any other property right of any person or entity or constitute defamation, libel, slander, trade disparagement, plagiarism or an invasion
of privacy.

 

Agency has the right to enter into this Agreement and is free to enter and fully perform the services hereunder.  Agency does not have any contract or other agreement with any other person or entity which might conflict or interfere or be inconsistent with any of the provisions of this Agreement or the enjoyment by China
Children Pharmaceutical of any rights granted hereunder.

 

INDEMNIFICATION.   Agency shall indemnify and hold China Children Pharmaceutical harmless from and against any and all losses, damages, liabilities, claims, demands, suits and expenses (including reasonable attorneys’ fees) that China Children Pharmaceutical
may incur or be liable for as a result of any claim, suit, or proceeding made or brought against China Children Pharmaceutical based upon or rising out of Agency’s negligence, willful misconduct, or any breach of its obligations or warranties contained in this Agreement.

 

China Children Pharmaceutical agrees to indemnify and hold harmless Agency from and against all losses, claims, damages, expenses or liabilities which it may incur based on information, representation, reports or data furnished to the Agency by China Children Pharmaceutical, to the extent that such material is relied upon by the Agency
and directly incorporated by Agency to provide services to China Children Pharmaceutical under this Agreement.

 

NOTICES.   All notices, approvals and other communications hereunder shall be effective only if in writing and either personally delivered or sent by registered or certified mail, return receipt requested, or by express mail or air express, or via electronic
mail.

 

TERMINATION.   Notwithstanding anything to the contrary contained elsewhere herein, China Children Pharmaceutical shall have the right to terminate this Agreement for any reason whatsoever by sixty (60) day written notice to Agency.  In the event
of such termination, China Children Pharmaceutical shall be released from all obligations under this Agreement, provided that China Children Pharmaceutical agrees to pay Agency for services performed hereunder prior to the date of termination on a pro-rata basis. Furthermore, upon termination, Agency shall immediately deliver to China Children Pharmaceutical all elements and related materials then in Agency’s possession relating to China Children Pharmaceutical and China Children Pharmaceutical shall have
the right to use all materials and information created by Agency under this Agreement.  No termination of Agency’s services hereunder shall affect China Children Pharmaceutical’s rights in or to the results and proceeds of Agency’s services theretofore rendered hereunder, or China Children Pharmaceutical’s rights at law

  

2

  

DONAHUE & ASSOCIATIONS

INVESTOR RELATIONS

 

and in equity, nor shall any termination affect any other rights granted to China Children Pharmaceutical by Agency hereunder.

 

GOVERNING LAW:   This agreement shall be deemed made in the State of New York and shall be construed in accordance with the laws of New York applicable to contracts entirely made and performed therein.

 

ENTIRE AGREEMENT.   The Agreement constitutes the entire understanding between the parties with respect to Agency’s services hereunder and supersedes all prior negotiations and understandings relating thereto.

 

 

The Agreement may not be modified or amended except by written instrument signed by the parties hereto.  The invalidity or illegality of any party of this Agreement shall not affect the validity or enforceability of any other part hereof.

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

 

	 	China Children Pharmaceutical, Inc.	 
	 	 	 	 
	
 
	
By: 
	 	 
	 	 	Jun Xia, Chief Executive Officer	 
	 	 	  	 
	 	Date: August 15, 2009	 
	 	 	 	 
	 	 	 	 
	 	China National Information Network	 
	 	 	 	 
	 	By:	 	 
	 	 	Joseph Donahue, Principal	 
	 	 	 	 
	 	Date: August 15, 2009	 

 

 

 

 

 

 

 

 

  

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00163-of-00352.parquet"}]]